Join to View Full Profile
1044 W Walnut StRm 202Indianapolis, IN 46202
Phone+1 317-274-0843
Fax+1 317-944-3349
Dr. Abonour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rafat Abonour is a hematologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Select Specialty Hospital of INpolis, Eskenazi Health, Indiana University Health University Hospital, and Indiana University Health North Hospital. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 32 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, and multiple myeloma.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1992 - 1994- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1991 - 1992
Aurora Health CareResidency, Internal Medicine, 1989 - 1991
Damascus University Faculty of MedicineClass of 1984
Certifications & Licensure
IN State Medical License 1995 - 2025
WI State Medical License 1990 - 2013
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Indianapolis Monthly Castle Connolly, 2011, 2013
Clinical Trials
- Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency Start of enrollment: 2012 Jan 01
- Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery Start of enrollment: 2018 Dec 10
- A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) Start of enrollment: 2021 Apr 20
- Join now to see all
Publications & Presentations
PubMed
- The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells.Hong Phuong Nguyen, Enze Liu, Anh Quynh Le, Mahesh Lamsal, Jagannath Misra
Molecular Therapy. Oncology. 2025-06-18 - 1 citationsReal-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.Karthik Ramasamy, Ravi Vij, David Kuter, David Cella, Brian G M Durie
Clinical Lymphoma, Myeloma & Leukemia. 2025-05-01 - Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectMM Registry.Howard R Terebelo, James Omel, Lynne I Wagner, James W Hardin, Robert M Rifkin
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-01
Abstracts/Posters
- A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor ActivityRafat Abonour, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect¬ MM R...Rafat Abonour, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect¬ MM RegistryRafat Abonour, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Healthcare Triage Podcast: Making Progress in Multiple Myeloma Research | the Incidental EconomistMarch 26th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
